Leading to Discontinuation of Treatment:Fifteen percent of approximately 25000 patients who received fluvoxamine in clinical trials discontinued treatment due to an adverse event. luvox and caffine more common events causing discontinuation from depression trials luvox and caffine nausea luvox and caffine vomiting, insomnia.

chills, chest pain, suicide attempt, fever, neck pain, infection, allergic reaction, accidental injury, flu syndrome.Rare: Overdose, face edema, hangover effect, abdomen enlarged, halitosis, neck luvox and caffine pelvic pain, hernia, chills and fever.Skin:Frequent: Sweating increased.Infrequent: Pruritus, rash.Rare: luvox and caffine acne, eczema, dry skin, alopecia, luvox and caffine furunculosis, Herpes simplex, Herpes zoster, luvox and caffine rash.Respiratory:Infrequent: Dyspnea, pharyngitis, rhinitis.Rare: Cough increased, luvox and caffine epistaxis, luvox and caffine luvox and caffine luvox and caffine laryngismus, hiccup, pneumonia, asthma, laryngitis, voice alternation.Special Senses:Infrequent: Taste perversion, tinnitus, amblyopia, abnormal luvox and caffine hyperacusis.Rare: Conjunctivitis, abnormality of accommodation, taste loss, luvox and caffine pain, lacrimation disorder, diplopia, dry eyes, mydriasis, ear pain, parosmia, deafness, phohobia, blepharitis.Musculoskeletal:Infrequent: Myalgia, arthralgia, myasthenia, tetany.Rare: Leg luvox and caffine arthrosis, rheumatoid.

of relation to drug, except those in terms so general as luvox and caffine be uninformative. Events are luvox and caffine classified.